And just where are the shares that are being sold coming from henry? As you said, its not the little guy.
> When the diabetes deal is announced...
Well, according to thestreet:
" With almost 33 million shares outstanding, the company has a healthy valuation of over half a billion and no product sales. But, if the murmuring is right, the Ligand deal, with what would be its eighth partner, could be a big one. Since the third week of August, Ligand's stock is up about 35%, trading Monday at 16. "
"[Ligand] is on some people's radar screens. A diabetes deal and cancer data puts it on a whole lot more," says Rich van den Broek, an analyst for Ligand banker Hambrecht & Quist. He cautions that completing a "deal always takes longer than you think."
> Tony, You have moaned and groaned
And try to keep this discussion civil. You show a bias whenever someone disagrees with you. |
